HIV/HCV coinfection, HAART, and liver-related mortality.

HIV/HCV coinfection, HAART, and liver-related mortality.

Bibliografiset tiedot
Päätekijät:	Sabin, C, Walker, A, Dunn, D
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2004

Samankaltaisia teoksia

Functional exhaustion of CD4<sup>+</sup>T cells in HIV/HCV coinfected HAART-treated patients
Tekijä: V. V. Vlasova, et al.
Julkaistu: (2023-06-01)

Virological Mechanisms in the Coinfection between HIV and HCV
Tekijä: Maria Carla Liberto, et al.
Julkaistu: (2015-01-01)

HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania
Tekijä: Camelia Sultana, et al.
Julkaistu: (2024-08-01)

Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
Tekijä: Emily L. Heil, et al.
Julkaistu: (2010-01-01)

Hospitalizations and deaths among people coinfected with HIV and HCV
Tekijä: Dorota Zarębska-Michaluk, et al.
Julkaistu: (2024-11-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
Tekijä: Ana Virseda-Berdices, et al.
Julkaistu: (2025-01-01)

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients
Tekijä: Daniel Fuster, et al.
Julkaistu: (2021-04-01)

HCV-HIV coinfection: simple messages from a complex disease.
Tekijä: Klenerman, P, et al.
Julkaistu: (2007)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
Tekijä: Beatriz Álvarez, et al.
Julkaistu: (2020-06-01)

HAART and Liver: A Discussion of Hepatic Disease in those Living with HIV
Tekijä: Curtis Cooper, et al.
Julkaistu: (2008-01-01)

Ethnicity and Spontaneous Clearance of Hepatitis C in HIV-HCV Coinfected Patients
Tekijä: Lil Miedzinski, et al.
Julkaistu: (2008-01-01)

Analytical and Biological Variables Influencing Quantitative Hepatitis C Virus (HCV) Measurement in HIV-HCV Coinfection
Tekijä: Curtis Cooper, et al.
Julkaistu: (2006-01-01)

Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man
Tekijä: S Yerly
Julkaistu: (2009-04-01)

CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients
Tekijä: Shikha Shrivastava, et al.
Julkaistu: (2021-10-01)

No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients
Tekijä: Julio Collazos, et al.
Julkaistu: (2024-03-01)

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV coinfected patients: an open-labelled comparison study
Tekijä: N Troilliet
Julkaistu: (2010-06-01)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada.
Tekijä: Adam Palayew, et al.
Julkaistu: (2021-01-01)

Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review
Tekijä: Paola Di Carlo, et al.
Julkaistu: (2015-01-01)

Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
Tekijä: Torti, C, et al.
Julkaistu: (2004)

Mortality Related to Chagas Disease and HIV/AIDS Coinfection in Brazil
Tekijä: Francisco Rogerlândio Martins-Melo, et al.
Julkaistu: (2012-01-01)

Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life Setting
Tekijä: Cristina Guadalupe Román López, et al.
Julkaistu: (2024-10-01)

Bystander Effects and Profibrotic Interactions in Hepatic Stellate Cells during HIV and HCV Coinfection
Tekijä: Cintia Cevallos, et al.
Julkaistu: (2024-01-01)

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
Tekijä: Solange Zacalusni Freitas, et al.
Julkaistu: (2014-12-01)

Antibodies to HIV-1 specific antigens in HBV and HCV coinfected patients in Warri, Nigeria
Tekijä: Mathew Olaniyan, et al.
Julkaistu: (2025-02-01)

Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients
Tekijä: C. Sangrador Pelluz, et al.
Julkaistu: (2014-01-01)

Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment
Tekijä: Paul Damien James, et al.
Julkaistu: (2012-01-01)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
Tekijä: Andrea Marino, et al.
Julkaistu: (2021-12-01)

Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.
Tekijä: Anjali Sharma, et al.
Julkaistu: (2015-01-01)

Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion.
Tekijä: Thiébaut, R, et al.
Julkaistu: (2006)

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
Tekijä: Daniel Sepúlveda-Crespo, et al.
Julkaistu: (2024-08-01)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
Tekijä: Martina Spaziante, et al.
Julkaistu: (2021-07-01)

The Effect of HBV/HCV in Response to HAART in HIV Patients after 12 Months in Kumba Health District in the South West Region of Cameroon
Tekijä: Adamu Ndongho Ndifontiayong, et al.
Julkaistu: (2021-08-01)

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
Tekijä: Porter, K, et al.
Julkaistu: (2003)

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
Tekijä: Aleksandra Berkan-Kawińska, et al.
Julkaistu: (2024-07-01)

HBV and HCV Coinfection among HIV/AIDS Patients in the National Hospital of Tropical Diseases, Vietnam
Tekijä: Bùi Vũ Huy, et al.
Julkaistu: (2014-01-01)

The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection
Tekijä: Leigh P. Johnson, et al.
Julkaistu: (2020-04-01)

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
Tekijä: Rubén Martín-Escolano, et al.
Julkaistu: (2024-10-01)

PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.
Tekijä: Sharp, C, et al.
Julkaistu: (2017)

Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations
Tekijä: N. V. Dunaeva, et al.
Julkaistu: (2022-07-01)

The experience of the Moscow City Center for AIDS Prevention and Treatment of using glecaprevir/pibrentasvir in patients with HIV/HCV coinfection
Tekijä: A. I. Mazus, et al.
Julkaistu: (2021-12-01)